PRADEEP ARUMUGAM

• Was highly dedicated and hardworking individual with exceptional managerial skills.
• Throughout the tenure here, I demonstrated a commitment to setting high standards for both learning and its practical application with diligence, sincerity, and dedication to the work allotted to me.
• Well-trained and has gained significant expertise in Hematopathology, particularly in areas such as peripheral smears morphology, bone marrow morphology, fluid cytology, coagulation studies
  cytochemistry reporting, independently reported more than 3000 bone marrow cases with flowcytometry for a diagnostic conclusion.
• In addition to I was exclusively trained in the field of DIagnostic Flow cytometry immunophenotyping inaccordance to latest WHO 2022 classification.
• CD34 stem cell enumeration by flow cytometry, CD4 and CD8 subset analysis and
  diagnostic flow cytometry for various conditions, including Acute Leukemia's, Myeloma, Lymphomas,
  MDS, and PNH.
• Trained also in high resolution Measurable residual disease (MRD) testing for B-ALL, T-ALL, and AML,MM,CLPD.
• I have been given thorough training in molecular techniques, including techniques for nucleic acid extraction by QIAGEN, PROMEGA and and manual methods in quantification (Pre-PCR),
• Exposed to analysis and trouble shooting of PCR techniques like RT-PCR, and RQ-PCR for CMLMRD monitoring and acute leukemia's.
• Exposed to sequencing techniques like Fragment Length Analysis for AML and MPN mutations by Sanger sequencing, as well as Chimerism analysis in Post-BMT patients
• Trained in reporting of NGS next generation sequencing including DNA/RNA sequencing by targeted gene panel

recommended by WHO/ ELN latest guidelines.

CME/CONFERENCES /PAPER PRESENTED /ATTENDED

PAPER PRESENTED AT CONFERNCE

1. Presented a oral paper Titled: Proposal of Mantle cell lymphoma Immunophenotypic scoring system (MCL-IPT), boon to early and reliable diagnosis at the cytometry society conferenceTCS-2023 Held at AIIMS,New Delhi.

2. Presented a poster titled : PAX5 fusions in Precursor B cell Lymphoblastic Leukemias: A single center experience by NGS and cytogenetics correlation at the Varanasi Hematology conference at 2024.

3. Presented 2 poster and oral presentations titled:

1. Does Ploidy status by flowcytometry correlate with cytogenetic studies: a single center experience and

2. Characterization of the T/NK-CLPDs by flow cytometry and correlation with clinical spectrum: a single centre experience.

3.Coauthored best oral paper of the hematocon 2025 in molecular category titled Dr Prateek das, molecular at Held in hematocon 2025 at Nagpur. Nagpur.chaercteristaion of T-ALL by Next generation sequencing.

PUBLICATIONS

PUBLICATIONS

1. Title: Aml-Myelodysplasia Related [Aml-Mr]: Cytogenetic Abnormalities, Molecular Profile and Treatment Outcomes in Newly Defined Aml Subtype. in European hematology association abstract book 2024.

2. A Comparative Analysis of Cytogenetic Aberrations,Mutation Profile and Post Induction Mrd in Etp and Non Etp Tacute Lymphoblastic Leukemia. . in European hematology association abstract book 2024.

3. Das Prateek, Kumar Sujeet, Ranjan Raghwesh, Arumugam Pradeep, Dhole Nilesh, Kori Rohit Kumar, Yadav Anil, Singh Anil, Kanwar Vikramjit, Singh Neha (2024) Should we perform baseline NGS testing in precursor T lymphoblastic leukaemias: a single centre experience from Eastern India ecancer 18 1815

4. Vishva, B., Pradeep, A., Mishra, N. et al. Metastatic Adenocarcinoma to Bone Marrow Presenting as Microangiopathic Hemolytic Anemia– Diagnostic Issues in a Series of Seven Young Adults. Indian J Hematol Blood Transfus (2024).https://doi.org/10.1007/s12288-024-01842-7

• SRL DIAGNOSTICS ( south reference lab) AT FORTIS HOSPITALS, BANGALORE HEMATOPATHOLOGY AND CLINICAL PATHOLOGY CYTOPATHOLOGY FLOWCYTOMETRY IMMUNOHISTOCHEMISTRY
• Was Section Head and part of the lab operations in hematopathology and flowcytometry
• Have got the NABL accreditation for flowcytometry department as a separate department.
• Individually signed out reports for special coagulation and more than 1000 bone marrow aspiration and bone marrow biopsies.
• Reported all special hematology including IHC. Successfully completed NABH, NABL and JCI audits in the department of hematopathology.
• Been as a trainer as a part of training to paramedical and DNB students
• Published many cases in ASH and presented papers in hematocon 2022
• Delivered expert talks in the educational forums of the hospital
• On the selection process of NABL lead assessor Training
• Undergone in trouble shooting and automation in hematology including cbc analyzer coagulation and flowcytometry
• Discussed hematopathology cases with the clinicians and conveyed timely reports.
• Initiated Digital hematology for routine practices

• Developed standard operating procedures for the pathology lab, ensuring consistency and quality of results.
• Optimized workflow within the lab by introducing new technologies and methodologies, increasing overall productivity.
• Attended various clinicopathological committee (CPC) meetings including gastroenterology, dermatology, obstetrics and gynecology, medicine and pediatrics.
• Attended and participated in tumor board meetings weekly .
• Undergone training program on Quality management system and internal audit in medical labs as per ISO15189‑2012 regarding NABL

• Skilled at working independently and collaboratively in a team environment.
• Incorporated CAP/RCPATH based reporting protocol in the field of diagnosis
• Conducted and participated in tumor board meetings weekly.
• Utilized more than 130 IHC markers in diagnosing challenging cases in the field of diagnostic pathology and hematopathology .
• Hands‑on experience in the analysis of Immunofluorescence staining in routine skin and renal biopsies.
• Exposure to frozen section with reporting of various surgical oncopathology cases Per day
• Exposed to routine cervical pap cytology by conventional and LBC techniques like thin prep and reported individually of about 40 pap smears per day .
• Exposed to exfoliative fluid cytology, and fine‑needle aspiration cytology.
• Handled USG guided Fnac individually in all the accessible sites for reporting. Understanding and routine reporting of peripheral smears, bone marrow aspirate, and trephine biopsies with exposure to various hematological and oncology disorders. · Exposure to immunophenotyping by flow cytometry for the subtyping of leukemia, lymphomas and in the diagnosis of PNH, Glanzman thrombasthenia.
• Individually had hands‑on experience in handling Flowcytometry and reporting according to the latest guidelines for about 6 months in the department of hematopathology under the guidance of DM hematopathologists ·
• Interpretation of IHC markers done on bone marrow biopsies for a specific staging and diagnosis.
• Actively participated in the oncopathology weekly and monthly CPC meetings in surgical pathology, cytopathology, and hematopathology sections.
• Worked in the cytopathology unit for a period of 6 months with exposure of about 20 FNAC cases

• NABL recognized authorized signatory in reporting routine and special hematology tests like a peripheral smear, bone marrow, and coagulation testing Participated as a pathologist in various inter‑lab ILQAS and EQAS programs
• Signed out routine cytological smears like FNAC and conventional pap smears individually.
• Performed procedures like USG guided FNACs and Bone marrow aspirates and biopsies
• Undergone training for a quality manager in the NABL and a member of the working core committee.
• Conducted monthly slide seminars for postgraduate students in pathology in histopathology, cytology, and hematology.